Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
To evaluate the efficacy and safety of low dose one week triple therapy with lansoprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori (H. pylori). A total of 103 patients with H. pylori infection who had gastritis, duodenal ulcer (DU) or gastric ulcer (GU) received 1 week's triple therapy of lansoprazole 30 g once daily (OD), amoxycillin 250 mg qid and clarithromycin 250 mg tid. The status of H. pylori infection was determined using the CLO test and histology (gram stain) of biopsy specimens during endoscopic examination. After treatment with triple therapy H. pylori infection was eradicated in 98 of 103 patients (95.15%), dyspeptic symptoms and upper gastrointestinal hemorrhage improved in 99 of 103 patients (96.1%). No adverse effect was observed in all the patients was received treatment. Low dose one-week triple therapy with lansoprazole, amoxycillin and clarithromycin is effective for eradication of H. pylori infection.